ASQUINO, ANGELA
 Distribuzione geografica
Continente #
EU - Europa 210
NA - Nord America 85
AS - Asia 75
SA - Sud America 14
AF - Africa 2
Totale 386
Nazione #
IT - Italia 151
US - Stati Uniti d'America 76
SG - Singapore 29
FI - Finlandia 18
KR - Corea 17
AR - Argentina 12
DE - Germania 12
IN - India 9
CA - Canada 7
JP - Giappone 6
BG - Bulgaria 5
FR - Francia 5
RU - Federazione Russa 5
IE - Irlanda 4
GB - Regno Unito 3
NL - Olanda 3
TW - Taiwan 3
AT - Austria 2
BR - Brasile 2
CN - Cina 2
IR - Iran 2
MA - Marocco 2
NO - Norvegia 2
CU - Cuba 1
HK - Hong Kong 1
ID - Indonesia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
TR - Turchia 1
VN - Vietnam 1
Totale 386
Città #
Rome 67
Singapore 19
Helsinki 17
Milan 14
Perugia 13
Santa Clara 10
Salt Lake City 8
Ashburn 7
Los Angeles 7
Florence 6
New York 6
Jena 5
Pomezia 5
San Isidro 5
Boardman 4
Dublin 4
Goyang-si 4
Sofia 4
Tokyo 4
Albano Laziale 3
Bengaluru 3
Chicago 3
Dongjak-gu 3
Hyderabad 3
Kolkata 3
Magog 3
Monte Grande 3
Munich 3
Somerville 3
Taipei 3
Amsterdam 2
Anguillara 2
Boulogne Sur Mer 2
Buenos Aires 2
Columbus 2
Incheon 2
Innsbruck 2
Jacksonville 2
Mapo-gu 2
Montreal 2
Monza 2
Nuneaton 2
Omaha 2
Oslo 2
Palermo 2
Portici 2
Reggio Calabria 2
Roanoke 2
Seoul 2
São Paulo 2
Ueda 2
Amasya 1
Bari 1
Beauharnois 1
Bellingham 1
Berlin 1
Beverly Hills 1
Charlottesville 1
Council Bluffs 1
Dallas 1
Edmonds 1
Genzano di Roma 1
Geumjeong-gu 1
Grugliasco 1
Havana 1
Ho Chi Minh City 1
Imbersago 1
Jakarta 1
Kalāheo 1
Karachi 1
Kuala Lumpur 1
Lappeenranta 1
Marrakesh 1
Moscow 1
Naples 1
Noto 1
Nuremberg 1
Paris 1
Pignola 1
Reston 1
Salerno 1
Tangier 1
Toronto 1
Trento 1
Troy 1
Verona 1
Washington 1
Totale 320
Nome #
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line 67
MGL lectin receptor and immunosuppression networks in glioblastoma 62
Circulating CD137+T cells as an immune biomarker for response to anti-PD1 immunotherapy in NSCLC patients 59
Treg/CD137+ T cell balance as a novel biomarker of survival in advanced non-addicted NSCLC patients treated with immunotherapy as first-line 38
Circulating immunosuppression correlates with worse clinical outcome in head and neck cancer patients undergoing immunotherapy treatment 36
Hedgehog driven regulatory network sustains chemoresistance and mesenchymal phenotype in Colorectal Cancer cells 35
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients 32
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs 23
Circulating CD137+ T cell levels are correlated with response to Pembrolizumab treatment in advanced head and neck cancer patients 23
Novel circulating biomarkers in HNSCC patients receiving anti-PD1 therapy: the predictive and prognostic role of immunosuppressive CD137+Treg cells and Lox-1+PMN-MDSCs 19
HHV-6A Infection of Papillary Thyroid Cancer Cells Induces Several Effects Related to Cancer Progression 9
Totale 403
Categoria #
all - tutte 1.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202311 0 0 0 0 0 0 0 0 0 0 0 11
2023/2024207 4 2 8 3 33 58 14 11 1 29 23 21
2024/2025185 39 28 34 25 32 27 0 0 0 0 0 0
Totale 403